Stay updated with breaking news from Yi Xing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers at Children's Hospital of Philadelphia (CHOP) and the University of California, Los Angeles (UCLA) have developed a computational platform capable of discovering tumor antigens derived from alternative RNA splicing, expanding the pool of cancer immunotherapy targets.
On the journey from gene to protein, a nascent RNA molecule can be cut and joined, or spliced, in different ways before being translated into a protein.
/PRNewswire/ -- On the journey from gene to protein, a nascent RNA molecule can be cut and joined, or spliced, in different ways before being translated into a...
/PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced four inaugural Class of 2022 TACTICAL (Therapy ACceleration To Intercept CAncer Lethality)...
Genetic variants that reduce the editing levels of double-stranded RNA are associated with autoimmune and immune-mediated conditions, a study finds.